Barclays PLC Takes Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)
Barclays PLC bought a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 54,886 shares of the company’s stock, valued at approximately $731,000. A number of other institutional investors and hedge funds […]
Barclays PLC bought a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 54,886 shares of the company’s stock, valued at approximately $731,000. A number of other institutional investors and hedge funds […]
